SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

37.32

97238.87

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.24

Back

rossari biotech ltd

Bajaj Finance consolidated net profit rises 27.37% in the June 2026 quarter

Aug 21,2026

Net profit of Bajaj Finance rose 27.37% to Rs 5985.75 crore in the quarter ended June 2026 as against Rs 4699.61 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 23023.46 crore in the quarter ended June 2026 as against Rs 19255.19 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	23023.46	19255.19	20
OPM %	71.11	70.28	-
PBDT	8436.55	6619.07	27
PBT	8149.00	6367.58	28
NP	5985.75	4699.61	27

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)